Next-generation therapeutics like antibodies and cell therapies hold immense promise, but their development is hampered by biological complexity and lengthy, expensive processes. Multi-omics approaches are emerging as critical tools to navigate these challenges, offering a comprehensive view of disease at the molecular level.
Share this article
AI/MLDrug Discoverymulti-omicsnext-generation therapiesresearch breakthroughscientific discovery
Comments